Historical Stock Price
ETFs Holding TAK »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
08/15/2019 $16.84 $16.92 $16.65 $16.86 1.11M
08/16/2019 $16.70 $16.79 $16.66 $16.72 749.20K
08/19/2019 $16.74 $16.82 $16.64 $16.80 1.68M
08/20/2019 $16.91 $16.91 $16.76 $16.77 902.90K
08/21/2019 $16.73 $16.73 $16.51 $16.51 1.40M
Takeda Pharmaceutical is a biopharmaceutical company with an innovative portfolio, engaged primarily in the research, development, production and marketing of pharmaceutical products. Co. has a geographically diversified global business and its prescription drugs are recognized brands in major countries worldwide. Co. is focused on four core therapeutic areas of oncology, gastroenterology, rare diseases, neuroscience along with targeted R&D investments in plasma-derived therapies and vaccines.
TAK historical stock prices picture
Takeda Pharmaceutical (TAK) has the following price history information. Looking back at TAK historical stock prices for the last five trading days, on August 15, 2019, TAK opened at $16.84, traded as high as $16.92 and as low as $16.65, and closed at $16.86. Trading volume was a total of 1.11M shares. On August 16, 2019, TAK opened at $16.70, traded as high as $16.79 and as low as $16.66, and closed at $16.72. Trading volume was a total of 749.20K shares. On August 19, 2019, TAK opened at $16.74, traded as high as $16.82 and as low as $16.64, and closed at $16.80. Trading volume was a total of 1.68M shares. On August 20, 2019, TAK opened at $16.91, traded as high as $16.91 and as low as $16.76, and closed at $16.77. Trading volume was a total of 902.90K shares. On August 21, 2019, TAK opened at $16.73, traded as high as $16.73 and as low as $16.51, and closed at $16.51. Trading volume was a total of 1.40M shares.

TAK Historical Stock Prices By Date:

TAK historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Takeda Pharmaceutical shares, starting with a $10,000 purchase of TAK, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/05/2010
End date: 08/21/2019
Start price/share: $21.37
End price/share: $16.51
Dividends collected/share: $0.00
Total return: -22.74%
Average Annual Total Return: -2.64%
Starting investment: $10,000.00
Ending investment: $7,729.21
Years: 9.63
Date Close
08/15/2019$16.86
08/16/2019$16.72
08/19/2019$16.80
08/20/2019$16.77
08/21/2019$16.51
TAK is categorized under the Materials sector; below are some other companies in the same sector:

TAM Historical Stock Prices
TAS Historical Stock Prices
TC Historical Stock Prices
TCC Historical Stock Prices
TCH Historical Stock Prices
TCK Historical Stock Prices
TEM Historical Stock Prices
TFR Historical Stock Prices
TG Historical Stock Prices
TGB Historical Stock Prices

TAK Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.